2Tunstall-Pedoe H., Kuulasmaa K. Contribution of trends in survival and coronary-event rates to changes in coronary heart disease mortality: 10 year results from 37 WHO MONICA Project populations[J]. Lancet, 1999,353(9164):1547-1557.
4Guy De Backer, Ettore Ambrosioni, Knut Borch-Johnsen, et al. European guidelines on cardiovascular disease prevention in clinical practice Third Joint Task Force of European and other Societies on Cardiovascular Disease Prevention in Clinical Practice[ J ] . European Journal of Cardiovascular Prevention and Rehabilitation ,2003, 10(Suppl 1):1-78.
5Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in adults (Adult Treatment Panel Ⅲ)[J ]. JAMA, 2001, 285(19) :2486-2497.
6Critchley J., Liu J., Zhao D., et al. Explaining the increase in coronary heart disease mortality in Beijing between 1984 and 1999[J ]. Circulation, 2004, 110(10):1236-1244.
7Stagmo M., Israelsson B., Brandstrom H., et al.. The swedish national programme for quality control of secondary prevention of coronary artery disease-results after one year[ J ].Eur J Cardiovasc Prev Rehabil, 2004, 11(1) :18-24.
8Conroy R. M., Pyorala K., Fitzgerald A. P., et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe:the SCORE project[J ]. Eur Heart J,2003, 24(11):987-1003.
9Pignone M., Sheridan S. L., Lee Y. Z., et al. Heart to heart: a computerized decision aid for assessment of coronary heart disease risk and the impact of risk-reduction interventions for primary prevention[ J ]. Prev Cardiol,2004,7(1):26-33.
10Kirby M. Applying the evidence: Guidelines in primary care[ J ]. Heart,2004, 90 (Suppl 4) :6-8.
